275 related articles for article (PubMed ID: 26659836)
1. A New View of Ras Isoforms in Cancers.
Nussinov R; Tsai CJ; Chakrabarti M; Jang H
Cancer Res; 2016 Jan; 76(1):18-23. PubMed ID: 26659836
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Conformations of KRAS Isoforms, K-Ras4A and K-Ras4B, Points to Similarities and Significant Differences.
Chakrabarti M; Jang H; Nussinov R
J Phys Chem B; 2016 Feb; 120(4):667-79. PubMed ID: 26761128
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional study examining the expression of splice variants K-RAS4A and K-RAS4B in advanced non-small-cell lung cancer patients.
Aran V; Masson Domingues P; Carvalho de Macedo F; Moreira de Sousa CA; Caldas Montella T; de Souza Accioly MT; Ferreira CG
Lung Cancer; 2018 Feb; 116():7-14. PubMed ID: 29413054
[TBL] [Abstract][Full Text] [Related]
4. PDEδ Binding to Ras Isoforms Provides a Route to Proper Membrane Localization.
Muratcioglu S; Jang H; Gursoy A; Keskin O; Nussinov R
J Phys Chem B; 2017 Jun; 121(24):5917-5927. PubMed ID: 28540724
[TBL] [Abstract][Full Text] [Related]
5. K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif.
Tsai FD; Lopes MS; Zhou M; Court H; Ponce O; Fiordalisi JJ; Gierut JJ; Cox AD; Haigis KM; Philips MR
Proc Natl Acad Sci U S A; 2015 Jan; 112(3):779-84. PubMed ID: 25561545
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing of the K-ras gene in mouse tissues and cell lines.
Wang Y; You M; Wang Y
Exp Lung Res; 2001; 27(3):255-67. PubMed ID: 11293328
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I.
Zhang FL; Kirschmeier P; Carr D; James L; Bond RW; Wang L; Patton R; Windsor WT; Syto R; Zhang R; Bishop WR
J Biol Chem; 1997 Apr; 272(15):10232-9. PubMed ID: 9092572
[TBL] [Abstract][Full Text] [Related]
8. The K-Ras 4A isoform promotes apoptosis but does not affect either lifespan or spontaneous tumor incidence in aging mice.
Plowman SJ; Arends MJ; Brownstein DG; Luo F; Devenney PS; Rose L; Ritchie AM; Berry RL; Harrison DJ; Hooper ML; Patek CE
Exp Cell Res; 2006 Jan; 312(1):16-26. PubMed ID: 16271715
[TBL] [Abstract][Full Text] [Related]
9. The hypervariable region of K-Ras4B is responsible for its specific interactions with calmodulin.
Abraham SJ; Nolet RP; Calvert RJ; Anderson LM; Gaponenko V
Biochemistry; 2009 Aug; 48(32):7575-83. PubMed ID: 19583261
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Acid Sphingomyelinase Depletes Cellular Phosphatidylserine and Mislocalizes K-Ras from the Plasma Membrane.
Cho KJ; van der Hoeven D; Zhou Y; Maekawa M; Ma X; Chen W; Fairn GD; Hancock JF
Mol Cell Biol; 2016 Jan; 36(2):363-74. PubMed ID: 26572827
[TBL] [Abstract][Full Text] [Related]
11. Flexible-body motions of calmodulin and the farnesylated hypervariable region yield a high-affinity interaction enabling K-Ras4B membrane extraction.
Jang H; Banerjee A; Chavan T; Gaponenko V; Nussinov R
J Biol Chem; 2017 Jul; 292(30):12544-12559. PubMed ID: 28623230
[TBL] [Abstract][Full Text] [Related]
12. The differential palmitoylation states of N-Ras and H-Ras determine their distinct Golgi subcompartment localizations.
Lynch SJ; Snitkin H; Gumper I; Philips MR; Sabatini D; Pellicer A
J Cell Physiol; 2015 Mar; 230(3):610-9. PubMed ID: 25158650
[TBL] [Abstract][Full Text] [Related]
13. K-RAS4A: Lead or Supporting Role in Cancer Biology?
Aran V
Front Mol Biosci; 2021; 8():729830. PubMed ID: 34604308
[TBL] [Abstract][Full Text] [Related]
14. K-Ras4A Plays a More Significant Role than K-Ras4B in Ductal Carcinoma of Breast.
Mortazavipour MM; Mohamadalizadeh-Hanjani Z; Geranpayeh L; Mahdian R; Shahbazi S
Iran Biomed J; 2023 Mar; 27(2 & 3):126-35. PubMed ID: 37070675
[TBL] [Abstract][Full Text] [Related]
15. Ras Isoforms from Lab Benches to Lives-What Are We Missing and How Far Are We?
Nair A; Kubatzky KF; Saha B
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204435
[TBL] [Abstract][Full Text] [Related]
16. The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas.
Nussinov R; Muratcioglu S; Tsai CJ; Jang H; Gursoy A; Keskin O
Mol Cancer Res; 2015 Sep; 13(9):1265-73. PubMed ID: 26085527
[TBL] [Abstract][Full Text] [Related]
17. Ras proteins: paradigms for compartmentalised and isoform-specific signalling.
Omerovic J; Laude AJ; Prior IA
Cell Mol Life Sci; 2007 Oct; 64(19-20):2575-89. PubMed ID: 17628742
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
Mazhab-Jafari MT; Marshall CB; Smith MJ; Gasmi-Seabrook GM; Stathopulos PB; Inagaki F; Kay LE; Neel BG; Ikura M
Proc Natl Acad Sci U S A; 2015 May; 112(21):6625-30. PubMed ID: 25941399
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of membrane binding of small GTPase K-Ras4B farnesylated hypervariable region.
Jang H; Abraham SJ; Chavan TS; Hitchinson B; Khavrutskii L; Tarasova NI; Nussinov R; Gaponenko V
J Biol Chem; 2015 Apr; 290(15):9465-77. PubMed ID: 25713064
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic K-Ras4B Dimerization Enhances Downstream Mitogen-activated Protein Kinase Signaling.
Muratcioglu S; Aydin C; Odabasi E; Ozdemir ES; Firat-Karalar EN; Jang H; Tsai CJ; Nussinov R; Kavakli IH; Gursoy A; Keskin O
J Mol Biol; 2020 Feb; 432(4):1199-1215. PubMed ID: 31931009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
